[HTML][HTML] Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs
A Prete, A Matrone, C Gambale, L Torregrossa… - Cancers, 2021 - mdpi.com
Simple Summary In the last decades, many researchers produced promising data
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
[PDF][PDF] Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs. Cancers 2021, 13, 3200
A Prete, A Matrone, C Gambale, L Torregrossa… - 2021 - pdfs.semanticscholar.org
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
[PDF][PDF] Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs. Cancers 2021, 13, 3200
A Prete, A Matrone, C Gambale, L Torregrossa… - Advances in the …, 2021 - core.ac.uk
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
A Prete, A Matrone, C Gambale, L Torregrossa… - …, 2021 - pubmed.ncbi.nlm.nih.gov
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
[PDF][PDF] Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs. Cancers 2021, 13, 3200
A Prete, A Matrone, C Gambale, L Torregrossa… - Advances in the …, 2021 - iris.unica.it
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
[PDF][PDF] Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs. Cancers 2021, 13, 3200
A Prete, A Matrone, C Gambale, L Torregrossa… - Advances in the …, 2021 - mdpi.com
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs.
A Prete, A Matrone, C Gambale, L Torregrossa… - Cancers, 2021 - europepmc.org
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
Poorly differentiated and anaplastic thyroid cancer: Insights into genomics, microenvironment and new drugs
A Prete, A Matrone, C Gambale, L Torregrossa… - CANCERS, 2021 - arpi.unipi.it
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs.
A Prete, A Matrone, C Gambale, L Torregrossa… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: In the last decades, many researchers produced promising data
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
concerning genetics and tumor microenvironment of poorly differentiated thyroid cancer …
Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
A Prete, A Matrone, C Gambale, L Torregrossa… - …, 2021 - search.proquest.com
PDTC and ATC present median overall survival of 6 years and 6 months, respectively. In
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …
spite of their rarity, patients with PDTC and ATC represent a significant clinical problem …